Risk and special populations

Cancer
32278878 ä. French Sarcoma Group proposals for management of sarcoma patients during the COVID-19 outbreak
32345594 2020. Patients with Cancer Appear More Vulnerable to SARS-COV-2: A Multicenter Study during the COVID-19 Outbreak

HIV other pharmacology

Drug abuse
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19

modifiable - tobacco
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic

indoor livin ppl

no sunlight no vitamin d

Psychiatry
32294689 2020. Schizophrenia and COVID-19: risks and recommendations

32334081 ä. HEALTH STATUS OF LIVER TRANSPLANTED PATIENTS DURING THE CORONAVIRUS OUTBREAK IN ITALY: A LARGE SINGLE CENTER EXPERIENCE FROM MILAN
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients

32353114 ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?

32300516 ä. Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times

32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers

32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease

32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?

32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China

32305831 ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment

32344292 2020. COVID-19 in lung cancer patients receiving ALK/ROS1 inhibitors

C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19

32222253 2020. COVID-19: lessons from the Italian reproductive medical experience

32323577 ä. What the oncologist needs to know about COVID-19 infection in cancer patients

32325028 ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost?

32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?

32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?

32297089 ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients

32224277 2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology
32199889 2020. Should biologics for psoriasis be interrupted in the era of COVID-19?
32283234 ä. Biologics for psoriasis during COVID-19 outbreak
32246966 ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution

32283235 ä. Various forms of skin rash in COVID-19 : a reply
32283233 ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection

32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy

32147409 ä. Are children less susceptible to COVID-19?

32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis

32335512 2020. Absence of severe complications from SARS-CoV-2 infection in children with rheumatic diseases treated with biologic drugs

32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection

32171057 2020. Implications of COVID-19 for patients with pre-existing digestive diseases

32224304 2020. COVID-19 infection in children

32332856 ä. COVID-19 in persons with haematological cancers

32344304 ä. May patients receiving 5-alpha-reductase inhibitors be in higher risk of COVID-19 complications ?
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease

32333196 2020. Lymphopenia that may develop in patients treated with temozolomide and immune control check-point inhibitor may be a high risk for mortality during the COVID-19 outbreak
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32271728 2020. Coronavirus Disease 2019 in Children - United States, February 12?April 2, 2020
32345328 2020. Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection
32218613 ä. Coronaviruserkrankung bei Kindern ? erste Daten aus Wuhan

32317808 ä. COVID-19 bei hospitalisierten Kindern und Jugendlichen: Ein systematischer Review zu publizierten Fallserien (Stand 31 03 2020) und erste Daten aus Deutschland

32187458 ä. SARS-CoV-2 Infection in Children
32163697 2020. Detection of Covid-19 in Children in Early January 2020 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far

32283004 ä. Universal Screening for SARS-CoV-2 in Women Admitted for Delivery
32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32303856 ä. Digital triage for people with multiple sclerosis in the age of COVID-19 pandemic
32270359 ä. Acute stroke management pathway during Coronavirus-19 pandemic
32270358 ä. No lockdown for neurological diseases during COVID19 pandemic infection
32364125 ä. Consulta de epilepsia durante la pandemia de Covid-19: papel de la telemedicina y efectos del confinamiento en pacientes epil�pticos
32364122 ä. Neuroinfecciones en tiempos de COVID-19

32346676 ä. Crowdsourcing a crisis response for COVID-19 in oncology

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China

32265531 ä. COVID-19 and cancer: what we know so far

32284613 ä. Characteristics of pediatric SARS-CoV-2 infection and potential evidence for persistent fecal viral shedding

32372803 2020. Children and covid-19
32243722 2020. Lessons unfolding from pediatric cases of COVID?19 disease caused by SARS?CoV?2 infection

32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19

32212348 2020. Why is COVID-19 so mild in children?
32339307 2020. Additional hypotheses about why COVID-19 is milder in children than adults
32279351 2020. We urgently need guidelines for managing COVID-19 in children with comorbidities

32311145 2020. SARS-CoV-2 infection in beta thalassemia: Preliminary data from the Italian experience
32243621 2020. COVID-19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
32267016 2020. Vaso-occlusive crisis and acute chest syndrome in sickle cell disease due to 2019 novel coronavirus disease (COVID-19)

32243894 2020. COVID-19 infection in cancer patients: early observations and unanswered questions
32224151 2020. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China

32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32369606 2020. COVID-19 Infection and Sickle Cell Disease: A UK Centre Experience
32314798 2020. COVID-19 infection in patients with sickle cell disease

32312714 2020. COVID-19 More Frequent, Severe in Cancer Patients
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend

32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms

32345646 2020. BTK inhibitors in cancer patients with COVID19: "The winner will be the one who controls that chaos" (Napoleon Bonaparte)

32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?

32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?

32329083 2020. (ang.)COVID-19 transmission through host cell directed network of GPCR

32239590 ä. Clinical findings in a patient with haemophilia A affected by COVID?19

32380214 ä. Clinical considerations for managing dermatology patients on systemic immunosuppressive and/or biologic therapy during COVID-19 pandemic

32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature

32376098 ä. A MULTINATIONAL REPORT TO CHARACTERISE SARS-CoV-2 INFECTION IN PEOPLE WITH CYSTIC FIBROSIS

32243919 2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab

32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19

32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32286926 2020. Is glucose-6-phosphate dehydrogenase enzyme deficiency a factor in Coronavirus-19 (COVID-19) infections and deaths?
32319118 2020. Two X-linked agammaglobulinemia patients develop pneumonia as COVID-19 manifestation but recover

32345686 2020. Vulnerable Youth and the COVID-19 Pandemic
32317311 2020. Mitigating the Impacts of the COVID-19 Pandemic Response on At-Risk Children

32348046 2020. Rhumatologie et COVID-19
32348045 2020. Maladies autoimmunes dans le contexte de la pandemie COVID-19
32348044 2020. L'hematologie au temps du COVID-19
32348042 2020. Infection a SARS-CoV-2 et transplantation d'organes solides

32387456 ä. Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (n=4532)

32387167 ä. The clinical observation of a patient with common variable immunodeficiency diagnosed as having coronavirus disease 2019
32376969 ä. COVID-19 outcomes in patients with hematologic disease

32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank

32388171 2020. SARS-COV-2 infection in patients with cancer undergoing checkpoint blockade: Clinical course and outcome
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?

32376043 ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak

32376098 ä. A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosis

32388230 2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia
32389426 2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...

32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection

32387757 2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a consequent of the associated immunodeficiency?

Risk and special populations

Version vom 12. Juni 2020, 17:20 Uhr

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

Meine Werkzeuge

Namensräume

Varianten

Ansichten

Aktionen

Suche

Navigation

Werkzeuge

@@ Zeile 39: / Zeile 39: @@
 '''[[RSP - HIV]]'''
+'''[[RSP - DIS Children]]'''
 '''[[RSP - DIS Elderly]]'''
@@ Zeile 45: / Zeile 47: @@
 '''[[RSP - DIS Race]]'''
-''' identifying factors '''
-'''Frailty'''
-'''Heart'''
-{{tp|p=32331955|t=ä. Cardiac injury is associated with mortality and critically ill pneumonia in COVID-19: A meta-analysis |pdf=|usr=}}
-{{tp|p=32326691|t=2020. Ticagrelor Can Be an Important Agent in the Treatment of Severe COVID-19 Patients with Myocardial Infarction |pdf=|usr=}}
-{{tp|p=32277299|t=2020. Perspective: cardiovascular disease and the Covid-19 pandemic |pdf=|usr=}}
-{{tp|p=32335068|t=ä. Unexpected BP Sensitivity to Angiotensin II in a Patient With Coronavirus Disease 2019, ARDS, and Septic Shock |pdf=|usr=}}
 '''Cancer'''
@@ Zeile 69: / Zeile 57: @@
 '''HIV'''
-{{tp|p=32266501|t=ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19 |pdf=|usr=}}
 '''other pharmacology'''
@@ Zeile 101: / Zeile 87: @@
-{{tp|p=32270178|t=ä. Early virus clearance and delayed antibody response in a case of COVID-19 with a  history of co-infection with HIV-1 and HCV |pdf=|usr=}}
 {{tp|p=32353114|t=ä. Throat Wash Testing and COVID-19 Disease: Should We Put Our Money Where Our Mouth Is?|pdf=|usr=}}
@@ Zeile 107: / Zeile 93: @@
-{{tp|p=32161990|t=ä. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China |pdf=|usr=}}
-{{tp|p=32328736|t=ä. No adequate evidence indicating hypertension as an independent risk factor for COVID-19 severity |pdf=|usr=}}
-{{tp|p=32357998|t=2020. Cardiac considerations in patients with COVID-19 |pdf=|usr=}}
-{{tp|p=32350632|t=2020. Cardiovascular Risks in Patients with COVID-19: Potential Mechanisms and Areas of Uncertainty |pdf=|usr=}}
@@ Zeile 132: / Zeile 109: @@
-{{tp|p=32322805|t=ä. SARS-CoV-2 pandemic expanding in sub-Saharan Africa: Considerations for COVID-19  in people living with HIV |pdf=|usr=}}
@@ Zeile 139: / Zeile 116: @@
 {{tp|p=32305831|t=ä. Flash Survey on SARS-CoV-2 Infections in Pediatric Patients on anti-Cancer Treatment |pdf=|usr=}}
-{{tp|p=32232395|t=ä. Initial COVID-19 affecting cardiac patients in China |pdf=|usr=}}
@@ Zeile 147: / Zeile 124: @@
-{{tp|p=32296994|t=ä. The double burden of disease of COVID-19 in cardiovascular patients: overlapping  conditions could lead to overlapping treatments |pdf=|usr=}}
 {{tp|p=C7141546|t=ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
@@ Zeile 156: / Zeile 133: @@
-{{tp|p=32341104|t=2020. Cardiovascular comorbidity and its impact on patients with Covid-19 |pdf=|usr=}}
@@ Zeile 169: / Zeile 146: @@
 {{tp|p=32323577|t=ä. What the oncologist needs to know about COVID-19 infection in cancer patients |pdf=|usr=}}
-{{tp|p=32244059|t=ä. SARS-CoV-2, COVID-19 and inherited arrhythmia syndromes |pdf=|usr=}}
-{{tp|p=32302703|t=ä. Considerations for Drug Interactions on QTc in Exploratory COVID-19 (Coronavirus  Disease 2019) Treatment |pdf=|usr=}}
-{{tp|p=32292696|t=ä. COVID-19 Infection Unmasking Brugada Syndrome |pdf=|usr=}}
 {{tp|p=32325028|t=ä. G6PD deficiency in COVID-19 pandemic: ?a ghost in the ghost? |pdf=|usr=}}
@@ Zeile 188: / Zeile 163: @@
-{{tp|p=32335339|t=ä. Case Report: One Case of Coronavirus Desease 2019(COVID-19) in Patient Co-nfected by HIV With a Low CD4+ T Cell Count |pdf=|usr=}}
@@ Zeile 217: / Zeile 192: @@
-{{tp|p=32347144|t=2020. Current perspectives on Coronavirus 2019 (COVID-19) and cardiovascular disease: A white paper by the JAHA editors |pdf=|usr=}}
 {{tp|p=32253068|t=2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy |pdf=|usr=}}
@@ Zeile 225: / Zeile 200: @@
-{{tp|p=32360995|t=ä. No evidence for an increased liver uptake of SARS-CoV-2 in metabolic associated fatty liver disease |pdf=|usr=}}
-{{tp|p=32278005|t=ä. Non-alcoholic fatty liver diseases in patients with COVID-19: A etrospective study |pdf=|usr=}}
-{{tp|p=32348791|t=ä. Clinical characteristics of COVID-19 patients with abnormal liver tests |pdf=|usr=}}
-{{tp|p=32348790|t=ä. Younger patients with MAFLD are at increased risk of severe COVID-19 illness: A multicenter preliminary analysis |pdf=|usr=}}
-{{tp|p=32305291|t=ä. Multicenter analysis of clinical characteristics and outcome of COVID-19 patients with liver injury |pdf=|usr=}}
@@ Zeile 266: / Zeile 235: @@
 {{tp|p=32171057|t=2020. Implications of COVID-19 for patients with pre-existing digestive diseases |pdf=|usr=}}
-{{tp|p=32304642|t=ä. COVID-19 in patients with HIV: clinical case series |pdf=|usr=}}
 {{tp|p=32224304|t=2020. COVID-19 infection in children |pdf=|usr=}}
@@ Zeile 337: / Zeile 306: @@
-{{tp|p=32231171|t=2020. Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis |pdf=|usr=}}
@@ Zeile 350: / Zeile 319: @@
-{{tp|p=32228252|t=2020. COVID-19, ACE2, and the cardiovascular consequences |pdf=|usr=}}
@@ Zeile 356: / Zeile 325: @@
 {{tp|p=32339307|t=2020. Additional hypotheses about why COVID-19 is milder in children than adults |pdf=|usr=}}
 {{tp|p=32279351|t=2020. We urgently need guidelines for managing COVID-19 in children with comorbidities |pdf=|usr=}}
-{{tp|p=32310898|t=2020. Infection of severe acute respiratory syndrome coronavirus 2 in a patient with acquired immunodeficiency syndrome |pdf=|usr=}}
@@ Zeile 371: / Zeile 340: @@
-{{tp|p=32339251|t=2020. The importance of hypertension as a risk factor for severe illness and mortality  in COVID-19 |pdf=|usr=}}
 {{tp|p=32243894|t=2020. COVID-19 infection in cancer patients: early observations and unanswered questions |pdf=|usr=}}
@@ Zeile 377: / Zeile 346: @@
-{{tp|p=32245656|t=2020. COVID-19 in patients with cardiovascular diseases |pdf=|usr=}}
@@ Zeile 410: / Zeile 379: @@
-{{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}}
 {{tp|p=32369240|t=2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind |pdf=|usr=}}
 {{tp|p=32367558|t=2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?|pdf=|usr=}}
@@ Zeile 441: / Zeile 410: @@
-{{tp|p=32220066|t=ä. SARS?CoV?2 and HIV |pdf=|usr=}}
-{{tp|p=32160316|t=ä. Co?infection of SARS?CoV?2 and HIV in a patient in Wuhan city, China |pdf=|usr=}}
-{{tp|p=32347975|t=2020. HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey |pdf=|usr=}}
-{{tp|p=32343410|t=2020. COVID-19 in Tuberculosis patients: a report of three cases |pdf=|usr=}}
-{{tp|p=32293709|t=2020. Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less  is better |pdf=|usr=}}
-{{tp|p=32285949|t=2020. Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19) |pdf=|usr=}}
 {{tp|p=32243919|t=2020. A Rapid Fatal Evolution of Coronavirus Disease-19 in a Patient With Advanced Lung Cancer With a Long-Time Response to Nivolumab |pdf=|usr=}}
@@ Zeile 463: / Zeile 419: @@
-{{tp|p=32251539|t=2020. COVID-19 and liver disease |pdf=|usr=}}
-{{tp|p=32329563|t=2020. Coronavirus disease 2019 and prevalence of chronic liver disease: A meta-analysis |pdf=|usr=}}
@@ Zeile 498: / Zeile 450: @@
-{{tp|p=C7187739|t=ä. Potential Impact of SARS-CoV-2 Infection in HIV-positive Patients in South Africa |pdf=|usr=}}
@@ Zeile 508: / Zeile 460: @@
 {{tp|p=32376969|t=ä. COVID-19 outcomes in patients with hematologic disease |pdf=|usr=}}
-{{tp|p=32381262|t=ä. Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission |pdf=|usr=}}
-{{tp|p=32402515|t=ä. Association of Cardiovascular Disease With Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis |pdf=|usr=}}
 {{tp|p=32413819|t=2020. Vitamin D concentrations and COVID-19 infection in UK Biobank |pdf=|usr=}}
@@ Zeile 517: / Zeile 469: @@
 {{tp|p=32291196|t=2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?|pdf=|usr=}}
-{{tp|p=32389521|t=2020. COVID-19 infection in patients following hepato-pancreatico-biliary intervention: An early experience |pdf=|usr=}}
-{{tp|p=32376408|t=ä. Clinical Characteristics and Outcomes of COVID-19 Among Patients with Pre-Existing Liver Disease in United States: A Multi-Center Research Network Study |pdf=|usr=}}
 {{tp|p=32376043|t=ä. Gynecological malignancies with asymptomatic SARS-CoV-2 infection during the convalescence of outbreak |pdf=|usr=}}
-{{tp|p=32380288|t=ä. Genetic susceptibility for COVID-19?associated sudden cardiac death in African Americans |pdf=|usr=}}
@@ Zeile 531: / Zeile 483: @@
-{{tp|p=32371279|t=ä. Therapeutic Strategy for Patients with Coronavirus Disease 2019 During Left Ventricular Assist Device Supports |pdf=|usr=}}
-{{tp|p=32305569|t=2020. Novel Coronavirus Disease 2019 in a Patient on Durable Left Ventricular Assist Device Support |pdf=|usr=}}
-{{tp|p=32408961|t=ä. Clinical course of patients infected with severe acute respiratory syndrome coronavirus 2 soon after thoracoscopic lung surgery |pdf=|usr=}}
-{{tp|p=32292915|t=ä. Severe COVID-19 With ARDS in a Patient on Durable LVAD Support |pdf=|usr=}}
 {{tp|p=32388230|t=2020. Covid-19 infection in therapy-naive patients with B-cell chronic lymphocytic leukemia |pdf=|usr=}}
 {{tp|p=32389426|t=2020. A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia: ...|pdf=|usr=}}
@@ Zeile 542: / Zeile 491: @@
 {{tp|p=32387757|t=2020. Is the oncologic patient more susceptible to covid19 but perhaps less likely to undergo severe infection-related complications due to fewer cytokines storm as a  consequent of the associated immunodeficiency?|pdf=|usr=}}
-{{tp|p=32389584|t=ä. Coronavirus disease 2019 (COVID-19) and cardiovascular risk: A meta-analysis |pdf=|usr=}}